Sexually transmitted infections may enhance the sexual transmission of HIV-1. It is possible that loss of virological control in patients with such infections receiving antiretroviral therapy (ART) may even facilitate the transmission of drug-resistant HIV. We have recently demonstrated that in those on maximally suppressive ART this effect is reduced. We have examined the virus obtained from the blood plasma and seminal plasma of six HIV-1-infected men receiving poorly suppressive ART with acute urethritis for the presence of drug resistance-associated mutations. In four men with gonorrhoea the blood and seminal plasma HIV-1 had mutations conferring reduced susceptibility to one or more available drugs. In one of these men the viral load of drug-resistant virus in seminal plasma was 20fold higher during gonorrhoea than following antibiotic treatment, with no change in blood plasma viral load. We conclude that in the presence of suboptimal ART, sexually transmitted infections may enhance the spread of drug-resistant HIV-1.
References
1.
UK Resistance Collaborative Group.Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom. British Medical Journal2001; 322: 1087–1088.
2.
PHLS Communicable Disease Surveillance Centre.AIDS and HIV Infection in the UK: Monthly report, January 2002. Communicable Diseases Report (CDR Weekly).
3.
CohenM.S., HoffmanI.F., RoyceR.A., KazembeP., DyerJ.R., DalyC.C., ZimbaD., VernazzaP.L., MaidaM., FiscusS.A., & EronJ.J.Jr.. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet1997; 349: 1868–1873.
4.
TachetA., DulioustE., SalmonD., De AlmeidaM., RivallandS., FinkielsztejnL., HeardI., JouannetP., SicardD., & RouziouxC.Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS1999; 13: 823–831.
5.
TaylorS., BackD.J., DrakeS.M., WorkmanJ., ReynoldsH., GibbonsS.E., WhiteD.J., & PillayD.Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir. Journal of Antimicrobial Chemotherapy2001; 48: 351–354.
6.
LiuzziG., ChirianniA., BagnarelliP., ClementiM., & PiazzaM.A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection. Antiviral Therapy1999; 4: 95–99.
7.
CoombsR.W., SpeckC.E., HughesJ.P., LeeW., SampoleoR., RossS.O., DragavonJ., PetersonG., HootonT.M., CollierA.C., CoreyL., KoutskyL., & KriegerJ.N.Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. Journal of Infectious Diseases1998; 177: 320–330.
8.
VernazzaP.L., TroianiL., FleppM.J., ConeR.W., SchockJ., RothF., BoggianK., CohenM.S., FiscusS.A., & EronJ.J.Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS2000; 14: 117–121.
9.
WinterA.J., TaylorS., WorkmanJ., WhiteD., RossJ.D., SwanA.V., & PillayD.Asymptomatic urethritis and detection of HIV-1 RNA in seminal plasma. Sexually Transmitted Infections1999; 75: 261–263.
10.
SadiqS.T., TaylorS., KayeS., BennettJ., JohnstoneR., ByrneP., CopasA.J., DrakeS.M., PillayD., & WellerI.The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. AIDS2002; 16: 219–225.
11.
SchaferR.Stanford HIV Resistance Data Base.http://hivdb.stanford.edu/. 2003. (Electronic Citation, last accessed 1-7-03).
12.
EronJ.J., VernazzaP.L., JohnstonD.M., Seillier-MoiseiwitschF., AlcornT.M., FiscusS.A., & CohenM.S.Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS1998; 12: F181–F189.
13.
EyreR.C., ZhengG., & KiesslingA.A.Multiple drug resistance mutations in human immunodeficiency virus in semen but not blood of a man on antiretroviral therapy. Urology2000; 55: 591.
14.
KroodsmaK.L., KozalM.J., HamedK.A., WintersM.A., & MeriganT.C.Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and proviral DNA. Journal of Infectious Diseases1994; 170: 1292–1295.
15.
MayerK.H., BoswellS., GoldsteinR., LoW., XuC., TuckerL., DePasqualeM.P., D'AquilaR., & AndersonD.J.Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clinical Infectious Diseases1999; 28: 1252–1259.
16.
LittleS.J., HolteS., RoutyJ.P., DaarE.S., MarkowitzM., CollierA.C., KoupR.A., MellorsJ.W., ConnickE., ConwayB., KilbyM., WangL., WhitcombJ.M., HellmannN.S., & RichmanD.D.Antiretroviral-drug resistance among patients recently infected with HIV. New England Journal of Medicine2002; 347: 385–394.
17.
GrantR.M., HechtF.M., WarmerdamM., LiuL., LieglerT., PetropoulosC.J., HellmannN.S., ChesneyM., BuschM.P., & KahnJ.O.Time trends in primary HIV-1 drug resistance among recently infected persons. Journal of the American Medical Association2002; 288: 181–188.
18.
DukersN.H., SpaargarenJ., GeskusR.B., BeijnenJ., CoutinhoR.A., & FennemaH.S.HIV incidence on the increase among homosexual men attending an Amsterdam sexually transmitted disease clinic: using a novel approach for detecting recent infections. AIDS2002; 16: F19–F24.
19.
CiccaroneD.H., KanouseD.E., CollinsR.L., MiuA., ChenJ.L., MortonS.C., & StallR.Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection. American.Journal of Public Health2003; 93: 949–954.
20.
TaylorS., SadiqS.T., SabinC., WhiteD., CaneP., DrakeS., & PillayD.Seminal super shedding of HIV: implications for sexual transmission.10th Conference on Retroviruses & Opportunistic Infections. Boston, Mass., USA, February 2003. Abstract 454.
